View Item 

Show simple item record

Complete Spontaneous Regression of Pulmonary Metastatic Melanoma
dc.contributor.authorWang, Timothy S.en_US
dc.contributor.authorLowe, Lorien_US
dc.contributor.authorSmith, John W.en_US
dc.contributor.authorFrancis, Isaac R.en_US
dc.contributor.authorSondak, Vernon K.en_US
dc.contributor.authorDworzanian, Lynnen_US
dc.contributor.authorFinkelstein, Stevenen_US
dc.contributor.authorSlingluff, Craig L.en_US
dc.contributor.authorJohnson, Timothy M.en_US
dc.date.accessioned2010-06-01T22:34:47Z
dc.date.available2010-06-01T22:34:47Z
dc.date.issued1998-08en_US
dc.identifier.citationWANG, TIMOTHY S.; LOWE, LORI; SMITH, JOHN W.; FRANCIS, ISAAC R.; SONDAK, VERNON K.; DWORZANIAN, LYNN; FINKELSTEIN, STEVEN; SLINGLUFF, CRAIG L.; JOHNSON, TIMOTHY M. (1998). "Complete Spontaneous Regression of Pulmonary Metastatic Melanoma." Dermatologic Surgery 24(8): 915-919. <http://hdl.handle.net/2027.42/75559>en_US
dc.identifier.issn1076-0512en_US
dc.identifier.issn1524-4725en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75559
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9723062&dopt=citationen_US
dc.description.abstractComplete spontaneous regression of melanoma metastatic to the lungs is a rare event. objective . To report a case of biopsy-proven melanoma metastatic to the lung with complete spontaneous regression. methods . Multidisciplinary case report. results . A 35-year-old white female was diagnosed with metastatic melanoma to the lung. A pleural biopsy confirmed the diagnosis. Partial spontaneous regression was noted by a staging computed tomography scan prior to enrollment in an investiga-tional protocol. Complete spontaneous regression occurred over 5 months without any form of conventional or alternative therapy, and the patient remains disease-free 3 years after diagnosis. conclusions . Our case represents the seventh case of complete spontaneous regression of melanoma metastatic to the lung, and the only case with histologic confirmation of both the primary and pulmonary metastatic lesions. The patient was pregnant twice between the time of her initial diagnosis of primary melanoma and pulmonary metastatic disease.en_US
dc.format.extent1621598 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1998 American Society for Dermatologic Surgery, Inc.en_US
dc.titleComplete Spontaneous Regression of Pulmonary Metastatic Melanomaen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Dermatology, University of Michigan Medical Center, and Univeristy of Michigan Comprehensive Cancer Center, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Medical Center, and Univeristy of Michigan Comprehensive Cancer Center, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Medicine, University of Michigan Medical Center, and Univeristy of Michigan Comprehensive Cancer Center, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Radiology, University of Michigan Medical Center, and Univeristy of Michigan Comprehensive Cancer Center, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Surgery, University of Michigan Medical Center, and Univeristy of Michigan Comprehensive Cancer Center, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherDepartment of Surgery, Univeristy of Virginia, Charlottesville, Virginia.en_US
dc.identifier.pmid9723062en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75559/1/j.1524-4725.1998.tb04275.x.pdf
dc.identifier.doi10.1111/j.1524-4725.1998.tb04275.xen_US
dc.identifier.sourceDermatologic Surgeryen_US
dc.identifier.citedreferenceEverson TC, Cole WH. Anonymous Spontaneous Regression of Cancer. Philadelphia: WB Saunders Co., 1966: 1 – 10, 164 – 220.en_US
dc.identifier.citedreferenceBoyd W. The spontaneous regression of cancer. In: Anonymous, ed. Springfield: Charles C. Thomas, 1966: 15 – 24.en_US
dc.identifier.citedreferenceBennett WH. Some peculiarities in the behavior of certain malignant and innocent growths. Lancet 1899; 1: 3 – 7.en_US
dc.identifier.citedreferenceBodurtha AJ. Spontaneous regression of malignant melanoma. In: Clark WH, Goldman LI, Mastrangelo JM, editors. Human Malignant Melanoma. New York: Grune & Stratton, 1979: 227 – 41.en_US
dc.identifier.citedreferenceSpitler LE. Malignant melanoma. J Invest Dermatol 1976; 67: 435 – 41.en_US
dc.identifier.citedreferenceMcGovern VJ. Spontaneous regression of melanoma. Pathol 1975; 7: 91 – 9.en_US
dc.identifier.citedreferenceBulkley GB, Cohen MH, Banks PM, Char DH, Ketcham AS. Long-term spontaneous regression of malignant melanoma with visceral metastases. Cancer 1975; 36: 485 – 94.en_US
dc.identifier.citedreferenceBodurtha AJ, Berkelhammer J, Kim YH, Laucius JF, Mastrangelo MJ. A clinical, histological and immunological study of a case of metastatic malignant melanoma undergoing spontaneous remission. Cancer 1976; 37: 735 – 42.en_US
dc.identifier.citedreferenceNathanson L. Spontaneous regression of malignant melanoma: A review of the literature on incidence, clinical features, and possible mechanisms. Nat Cancer Inst Monogr 1976; 67 – 76.en_US
dc.identifier.citedreferenceCole WH. Spontaneous regression of cancer: The metabolic triumph of the host? Ann NY Acad Sci 1974; 230: 111 – 41.en_US
dc.identifier.citedreferenceRohdenburg GL. Fluctuations in the growth energy of malignant tumors in man, with special reference to spontaneous regression. J Cancer Res 1918; 3: 193 – 225.en_US
dc.identifier.citedreferenceMikhail GR, Gorsulowsky DC. Spontaneous regression of metastatic malignant melanoma. J Dermatol Surg Oncol 1986; 12: 497 – 500.en_US
dc.identifier.citedreferenceRampen FHJ, Meijer J. Metastatic melanoma of the brain after sontaneous regression of the primary. Acta Neurol Scand 1985; 72: 222 – 3.en_US
dc.identifier.citedreferencePellegrini AE. Regressed primary malignant melanoma with regional metastasis. Arch Dermatol 1980; 116: 585 – 6.en_US
dc.identifier.citedreferenceGromet MA, Epstein WL, Blois MS. The regressing thin malignant melanoma: a distinctive lesion with metastatic potential. Cancer 1978; 42: 2282 – 92.en_US
dc.identifier.citedreferenceSroujieh AS. Spontaneous regression of intestinal malignant melanoma from an occult primary site. Cancer 1988; 62: 1247 – 50.en_US
dc.identifier.citedreferenceHurwitz PJ. Spontaneous regression of metastatic melanoma. Ann Plast Surg 1991; 26: 403 – 6.en_US
dc.identifier.citedreferenceShai A, Avinoach I, Sagi A. Metastatic malignant melanoma with spontaneous and complete regression of the primary lesion. J Dermatol Surg Oncol 1994; 20: 342 – 5.en_US
dc.identifier.citedreferenceAvril MF, Charpentier P, Margulis A, Guillaume JC. Regression of primary melanoma with metastases. Cancer 1992; 69: 1377 – 81.en_US
dc.identifier.citedreferencePogrebniak HW, Stovroff M, Roth JA, Pass HI. Resection of pulmonary metastases from malignant melanoma: results of a 16-year experience. Ann Thorac Surg 1988; 46: 20 – 3.en_US
dc.identifier.citedreferenceJohnson TM, Smith JW, Nelson BR, Chang A. Current therapy for cutaneous melanoma. J Am Acad Dermatol 1995; 32: 689 – 707.en_US
dc.identifier.citedreferenceBalch CM, Soong S, Murad TM, Smith JW, Maddox WA, Durant JR. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1983; 1: 126 – 34.en_US
dc.identifier.citedreferenceAmer MH, Al-Sarraf M, Vaitkevicius VK. Clinical presentation, natural history and prognostic factors in advanced malignant melanoma. Surg Gynecol Obstet 1979; 149: 687 – 92.en_US
dc.identifier.citedreferenceStehlin JS, Hills WJ, Rufino C. Disseminated melanoma. Biologic behavior and treatment. Arch Surg 1967; 94: 495 – 501.en_US
dc.identifier.citedreferenceHarpole DH, Johnson CM, Wolfe WG, George SL, Seigler HF. Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 1992; 103: 743 – 50.en_US
dc.identifier.citedreferenceSlingluff CL Jr, Reintgen DS, Volmer RT, Seigler MF. Malignant melanoma arising during pregnancy: A study of 100 patients. Ann Surg 1990; 211: 552 – 9.en_US
dc.identifier.citedreferenceShiu MH, Schottenfeld D, MacLean B, Former JG. Adverse effects of pregnancy on melanoma: a reappraisal. Cancer 1976; 37: 181 – 7.en_US
dc.identifier.citedreferenceWong JH, Sterns EE, Kopland KH, Nizze JA, Morton DL. Prognostic significance of pregnancy in stage I melanoma. Arch Surg 1989; 124: 1227 – 30.en_US
dc.identifier.citedreferenceElwood JM, Coldman AJ. Previous pregnancy and melanoma prognosis (letter). Lancet 1978; 2: 1000 – 1.en_US
dc.identifier.citedreferenceGeorge PA, Former SG, Pack GT. Melanoma with pregnancy: a report of 115 cases. Cancer 1960; 13: 854 – 9.en_US
dc.identifier.citedreferenceHersey P, Morgan G, Stone DE, McCarthy WH, Milton GW. Previous pregnancy as a protective factor against death from malignant melanoma. Lancet 1977; 2: 451 – 2.en_US
dc.identifier.citedreferenceHoughton AN, Flannery J, Viola MV. Malignant melanoma of the skin occurring during pregnancy. Cancer 1983; 48: 407 – 10.en_US
dc.identifier.citedreferenceSutherland CM, Loutfi A, Mather FJ, Carter RD, Krementz ET. Effect of pregnancy on malignant melanoma. Surg Gynecol Ob-stet 1983; 157: 443 – 6.en_US
dc.identifier.citedreferenceWeiss NS, Flannery JT. The relationship of marital status to survival from melanoma. Cancer 1978; 42: 296 – 8.en_US
dc.identifier.citedreferenceRosenberg SA. Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens. J Natl Cancer Inst 1996; 88: 1635 – 44.en_US
dc.identifier.citedreferenceSlingluff CL. Tumor antigens and tumor vaccines: peptides as immunogens. Sem Surg Oncol 1996; 12: 446 – 53.en_US
dc.identifier.citedreferenceSkipper JC, Hendrickson RC, Gulden PH, et al. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from post-translational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med 1996; 183: 527 – 34.en_US
dc.identifier.citedreferenceWolfel T, Van Pel A, Brichard V, et al. Two tyrosinase nonapep-tides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 1994; 24: 759 – 64.en_US
dc.identifier.citedreferenceKang X, Kawakami Y, el-Gamil M, et al. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J Immunol 1995; 155: 1343 – 8.en_US
dc.identifier.citedreferenceBrichard VG, Herman J, Van Pel A, et al. A tyrosinase nonapep-tide presented by HLA-B44 is recognized on a human melanoma by autologous cytolyric T lymphocytes. Eur J Immunol 1996; 26: 224 – 30.en_US
dc.identifier.citedreferenceCox AL, Skipper J, Chen Y, et al. Identification of a peptide recognized by five melanoma specific human cytotoxic T cell lines. Science 1994; 264: 716 – 9.en_US
dc.identifier.citedreferenceBakker AB, Schreurs MW, Tafazzul G, et al. Identification of a novel peptide derived from the melanocyte-specific gp 100 antigen as the dominant epitope recognized by an HLA-A2.1-re-stricted anti-melanoma CTL line. Int J Cancer 1995; 62: 97 – 102.en_US
dc.identifier.citedreferenceKawakami Y, Eliyahu S, Jennings C, et al. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol 1995; 154: 3961 – 8.en_US
dc.identifier.citedreferenceBakker AB, Schreurs MW, de Boer AJ, et al. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived rumor-infiltrating lymphocytes. J Exp Med 1994; 179: 1005 – 9.en_US
dc.identifier.citedreferenceKawakami Y, Eliyahu S, Delgado CH, et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 1994; 91: 6458 – 62.en_US
dc.identifier.citedreferenceSkipper JC, Kittlesen DJ, Hendrikson RC, et al. Shared epitopes for HLA-A3 restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100. J Immunol 1996; 157: 5027 – 33.en_US
dc.identifier.citedreferenceCoulie PG, Brichard V, Van Pel A, et al. A new gene encoding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994; 180: 35 – 42.en_US
dc.identifier.citedreferenceKawakami Y, Eliyahu S, Sakaguchi K, et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 1994; 180: 347 – 52.en_US
dc.identifier.citedreferenceCastelli C, Storkus WJ, Maeurer MJ, et al. Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes. J Exp Med 1995; 181: 363 – 8.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1524-4725.1998.tb04275.x.pdf
Size:
1.546MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.